Cargando…

Editorial: Immunological Mechanisms, Biomarkers and Immunotherapies of Alzheimer's Disease

Detalles Bibliográficos
Autores principales:	Xin, Jia-yan, Zhu, Xiao-yan, Huang, Xiao, Liu, Yu-hui, Tan, Jun, Xiang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473822/ https://www.ncbi.nlm.nih.gov/pubmed/34588975 http://dx.doi.org/10.3389/fnagi.2021.733282

Ejemplares similares

Editorial: Biomarkers of Alzheimer’s Disease: The Present and the Future
por: Lehmann, Sylvain, et al.
Publicado: (2016)

Electrophysiological Biomarkers of Epileptogenicity in Alzheimer’s Disease
por: Yu, Tingting, et al.
Publicado: (2021)

Optimal Combinations of AT(N) Biomarkers to Determine Longitudinal Cognition in the Alzheimer's Disease
por: Lin, Rong-Rong, et al.
Publicado: (2021)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Editorial: Mechanisms, markers and therapeutics of synaptic pathology in Alzheimer's disease
por: Metaxas, Athanasios, et al.
Publicado: (2022)

The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer’s Disease: Exploring Interactions With Sex
por: Liu, Ying, et al.
Publicado: (2021)

Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: Molecular mechanisms, biomarkers, diagnosis, and therapies, volume II
por: Jiang, Jiehui, et al.
Publicado: (2022)

Editorial: Immunology and inflammation in intracranial aneurysms
por: Liu, Qingyuan, et al.
Publicado: (2022)

Association Between Plasma Apolipoprotein M With Alzheimer’s Disease: A Cross-Sectional Pilot Study From China
por: Xin, Jia-Yan, et al.
Publicado: (2022)

Clinical Features and Potential Mechanisms Relating Neuropathological Biomarkers and Blood-Brain Barrier in Patients With Alzheimer’s Disease and Hearing Loss
por: Zhang, Wei-jiao, et al.
Publicado: (2022)

Systematic evaluation of urinary formic acid as a new potential biomarker for Alzheimer’s disease
por: Wang, Yifan, et al.
Publicado: (2022)

The Role of Non-coding RNAs in Alzheimer’s Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers
por: Zhang, Yuan, et al.
Publicado: (2021)

Editorial: Alzheimer's Disease and the Fornix
por: Oishi, Kenichi, et al.
Publicado: (2016)

Editorial: The Alzheimer's Disease Challenge
por: Alexiou, Athanasios, et al.
Publicado: (2019)

Editorial: Metabolism in Alzheimer's Disease
por: Morris, Jill K., et al.
Publicado: (2022)

Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Editorial: Advancements in immunology and immunotherapy for breast cancer
por: Sugie, Tomoharu, et al.
Publicado: (2022)

Editorial: NK cells in viral immunology and immunotherapy
por: Mulik, Sachin, et al.
Publicado: (2023)

Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum
por: Chen, Yi-He, et al.
Publicado: (2022)

Immunotherapy for Alzheimer’s disease: past, present and future
por: Spencer, Brian, et al.
Publicado: (2014)

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease
por: Sumner, Isabelle L., et al.
Publicado: (2018)

Editorial: Nutrition and prevention of Alzheimer's disease
por: Perez-Cruz, Claudia, et al.
Publicado: (2015)

Editorial: Neurophysiology in Alzheimer's Disease and Dementia
por: Moretti, Davide V.
Publicado: (2016)

Editorial: Risk Factors for Alzheimer's Disease
por: Moreno-Gonzalez, Ines, et al.
Publicado: (2020)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

The Eye As a Biomarker for Alzheimer's Disease
por: Lim, Jeremiah K. H., et al.
Publicado: (2016)

Editorial: Mitochondrial and lysosomal dysfunction in neurodegenerative diseases: Molecular mechanisms and therapeutic strategies
por: Xiang, Chen, et al.
Publicado: (2022)

Editorial: Alzheimer-related affective symptoms – mechanism and treatment
por: Nitzan, Keren, et al.
Publicado: (2023)

Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
por: Abu Eid, Rasha
Publicado: (2019)

Editorial: Focus on malignant pleural mesothelioma immunology and immunotherapy
por: Porta, Chiara, et al.
Publicado: (2023)

Expression of the Excitatory Postsynaptic Scaffolding Protein, Shank3, in Human Brain: Effect of Age and Alzheimer’s Disease
por: Wan, Lily, et al.
Publicado: (2021)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Editorial: The Alzheimer's disease challenge, volume II
por: Kamal, Mohammad Amjad, et al.
Publicado: (2023)

Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics Analysis
por: Yu, Wuhan, et al.
Publicado: (2021)

Plasma biomarkers and their correlation in adult children of parents with Alzheimer’s disease
por: Huang, Ling-Chun, et al.
Publicado: (2022)

An atlas on biomarkers for Alzheimer's disease
por: Martínez-Rivera, Marta
Publicado: (2013)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

Screening of Human Circular RNAs as Biomarkers for Early Onset Detection of Alzheimer’s Disease
por: Zheng, Da, et al.
Publicado: (2022)

Ophthalmic Biomarkers for Alzheimer’s Disease: A Review
por: Majeed, Ayesha, et al.
Publicado: (2021)

Immunological and hormonal mechanisms in Alzheimer’s disease
por: Trifu, Simona Corina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4m4pmh33i6fsif8he72du0uvcs